EM-T3Expert Opinion on Drug Safety2018-03-22第 17 卷第 5 期,445-450
A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence